126 related articles for article (PubMed ID: 6969833)
1. [Relationship between surgery, chemotherapy, irradiation and immunological state in patients of laryngeal cancer (author's transl)].
Krajina Z; Kosoković F; Bolanca S; Bumber Z
Laryngol Rhinol Otol (Stuttg); 1980 Jun; 59(6):341-3. PubMed ID: 6969833
[TBL] [Abstract][Full Text] [Related]
2. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.
Farrag TY; Lin FR; Cummings CW; Koch WM; Flint PW; Califano JA; Broussard J; Bajaj G; Tufano RP
Laryngoscope; 2006 Oct; 116(10):1864-6. PubMed ID: 17003711
[TBL] [Abstract][Full Text] [Related]
3. [Induction chemotherapy and larynx preservation: is such practice useful?].
Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
[TBL] [Abstract][Full Text] [Related]
4. Results of treatment of inoperable recurrences of laryngeal cancer after total laryngectomy.
Sas-Korczyńska B; Korzeniowski S; Skolyszewski J
Strahlenther Onkol; 1996 Feb; 172(2):99-102. PubMed ID: 8669051
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
[TBL] [Abstract][Full Text] [Related]
6. [The assessment of laryngectomy and radical neck dissection in the treatment of laryngeal cancers (author's transl)].
Tu GY
Zhonghua Yi Xue Za Zhi; 1981 Jan; 61(1):16-20. PubMed ID: 6805874
[No Abstract] [Full Text] [Related]
7. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy.
Lecanu JB; Monceaux G; Périé S; Angelard B; St Guily JL
Laryngoscope; 2000 Mar; 110(3 Pt 1):412-6. PubMed ID: 10718429
[TBL] [Abstract][Full Text] [Related]
8. Evolution of the management of laryngeal cancer.
Genden EM; Ferlito A; Silver CE; Jacobson AS; Werner JA; Suárez C; Leemans CR; Bradley PJ; Rinaldo A
Oral Oncol; 2007 May; 43(5):431-9. PubMed ID: 17112771
[TBL] [Abstract][Full Text] [Related]
9. [State of anti-infection immunity in laryngeal cancer patients undergoing combined and radical radiation treatment].
Kochetkova VA; Demidov VP; Poluéktova NA; Bitiutskiĭ PG; Trofimov EI
Vestn Otorinolaringol; 1980; (5):45-9. PubMed ID: 7414826
[No Abstract] [Full Text] [Related]
10. Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II--Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group.
Hillman RE; Walsh MJ; Wolf GT; Fisher SG; Hong WK
Ann Otol Rhinol Laryngol Suppl; 1998 May; 172():1-27. PubMed ID: 9597955
[TBL] [Abstract][Full Text] [Related]
11. Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer.
Holsinger FC; Funk E; Roberts DB; Diaz EM
Head Neck; 2006 Sep; 28(9):779-84. PubMed ID: 16637055
[TBL] [Abstract][Full Text] [Related]
12. [New and controversial concepts in the treatment of laryngeal cancer].
Kleinsasser O
Arch Otorhinolaryngol Suppl; 1985; 2():10-7. PubMed ID: 3938658
[No Abstract] [Full Text] [Related]
13. [Surgical management and preservation of laryngeal function for senile patients with advanced laryngeal carcinoma].
Zhang DG; Zhang HB; Luan XY; Pan XL; Xie G
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):379-81. PubMed ID: 17892137
[TBL] [Abstract][Full Text] [Related]
14. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
[TBL] [Abstract][Full Text] [Related]
15. [Hypothyroidism in patients treated for laryngeal cancer: preliminary results].
Romero A; Esteban F; Delgado M; Solanellas J; Soldado L; Fernández I; Hidalgo J; Rodríguez Adrados F
Acta Otorrinolaringol Esp; 1999 Apr; 50(3):205-10. PubMed ID: 10362864
[TBL] [Abstract][Full Text] [Related]
16. [The prognostic value of the time of progression of symptoms and signs in carcinomas of the pharyngo-larynx (author's transl)].
Laccourreye H; André P
Ann Otolaryngol Chir Cervicofac; 1978 Mar; 95(3):149-77. PubMed ID: 666221
[TBL] [Abstract][Full Text] [Related]
17. [Laryngeal Preservation with Induction Chemotherapy. Experience of two GETTEC Centers, Between 1985 and 1995].
Janot F; Rhein B; Koka VN; Wibault P; Domenge C; Bessede JP; Marandas P; Schwaab G; Luboinski B
Ann Otolaryngol Chir Cervicofac; 2002 Feb; 119(1):12-20. PubMed ID: 11965102
[TBL] [Abstract][Full Text] [Related]
18. [Epitheliomas of the anterior margin of the larynx. A study of 102 cases (author's transl)].
Laccourreye H; Brasnu D; Beutter P; Bodard M
Ann Otolaryngol Chir Cervicofac; 1980 Dec; 97(12):977-81, 984-93. PubMed ID: 7247214
[TBL] [Abstract][Full Text] [Related]
19. Immune reactivity does not predict chemotherapy response, organ preservation, or survival in advanced laryngeal cancer.
Wolf GT; Bradford CR; Urba S; Smith A; Eisbruch A; Chepeha DB; Teknos TN; Worden F; Dawson L; Terrell JE; Hogikyan ND
Laryngoscope; 2002 Aug; 112(8 Pt 1):1351-6. PubMed ID: 12172244
[TBL] [Abstract][Full Text] [Related]
20. [The cellular immunologic status of the laryngeal cancer patients].
Huang Z; Han D; Bian Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(2):107-9. PubMed ID: 9387505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
